Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v4-EN
Language English English
Date Updated 2019-11-27 2017-08-24
Drug Identification Number 02421712 02421712
Brand name DUTASTERIDE DUTASTERIDE
Common or Proper name DUTASTERIDE DUTASTERIDE
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients DUTASTERIDE DUTASTERIDE
Strength(s) 0.5MG 0.5MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 30 30
ATC code G04CB G04CB
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-08-17 2017-08-17
Estimated end date Unknown
Actual end date 2019-11-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments